Letter to US Trade Representative on WTO LDC Group’s Request for Pharmaceutical Waiver Extension

LDC Watch calls on the United States for full and unconditional support to the “duly motivated request” of the WTO LDC Group in accordance with Article 66.1 of the TRIPS Agreement.

See also:

• LDC Group’s Request for Extension of TRIPS Pharmaceutical Waiver Well Received at the TRIPS Council Meeting, 9-10 June, Geneva

(File) LDC Watch Letter to UST – 293 kB (File Size)